This will only make the rise appear "more impressive." Stand on that good, solid, long ground. When the rise begins, all of the nay sayers "immediately" go silent. Like dust in the wind. Good will always prevail.
Its all about the data now. If dosing really makes a difference it will show up in this study. They have no other results other than the Phase1 for this level of dosing and in the Phase 1 there was a PR in triple negative that showed increasing tumor elimination over time. It was actually a SD that turned into a PR between month 2 and month 4. Triple negative may be our ace in the hole.